Wilson Wong, PhD
Professor
Boston University College of Engineering
Biomedical Engineering

PhD, University of California, Los Angeles
BS, University of California, Berkeley



Wilson Wong is an Assistant Professor for Biomedical Engineering at Boston University. He obtained his PhD in chemical engineering from the University of California, Los Angeles and his Bachelor's in chemical engineering from the University of California, Berkeley. His research interests are in applying metabolic engineering and immune cell engineering to rapidly and predictably engineer desired properties in human immune cells to treat diseases.

The Wong lab is a DESIGN driven lab where they apply synthetic biology to engineer desired properties in mammalian cells, with application in understanding cellular design principle and to treat diseases. One area that they are interested in is engineering genetic circuits to improve the efficacy and safety of adoptive T cell therapy. Here they are interested in using synthetic biology to design and construct novel signaling, transcription, and metabolic networks in cells for application in medicine and understanding design principles in living organisms. Specifically, they are interested in engineering human immune cells for adoptive cancer immunotherapy. Adoptive immunotherapy is a promising therapy for treatment of various cancers (1). Their goal at the Wong Lab is to engineer immune cells to enhance their disease fighting capability while minimizing adverse side effect. Also, by building novel networks inside immune cells, they can explore design principles by mapping network architecture to phenotype.


Modified saRNA Encoded BiTEs for Lung Cancer
01/01/2025 - 12/31/2029 (Co-Investigator)
PI: Mark Grinstaff, PhD
NIH/National Cancer Institute
1R01CA296810-01

Synthetic circuit technologies for precision control and signal processing in mammalian cells
08/12/2024 - 04/30/2028 (Co-Investigator)
PI: Ahmad (Mo) Khalil, PhD
NIH/National Institute of Biomedical Imaging & Bioengineering
5R01EB029483-06

Engineering recombinase circuits for cellular diagnostic devices
08/01/2024 - 04/30/2028 (PI)
NIH/National Institute of Biomedical Imaging & Bioengineering
5R01EB036085-02

ROGUE-Rx On-site generation Using Electronics
09/16/2024 - 09/15/2027 (Multi-PI)
PI: Wilson Wong, PhD
Carnegie Mellon University ARPA-H


Synthetic morphogenesis to recapitulate multicellular patterns for regenerative medicine
09/01/2025 - 08/31/2027 (Key Person / Mentor)
PI: Ian Kinstlinger, PhD
NIH/National Heart, Lung, and Blood Institute
1K99HL177312-01A1

Development and characterization of self-amplifying RNA Lipid Nanoparticles for potent and multiplex gene expression in solid tumors
07/01/2024 - 06/30/2027 (Key Person / Mentor)
NIH/National Cancer Institute
5F31CA295073-02

Precise tumor targeting with logic CAR circuits
09/17/2021 - 08/31/2026 (Multi-PI)
PI: Wilson Wong, PhD
NIH/National Cancer Institute
5U01CA265713-04

Precise targeting of T1D specific T cells using CAR and peptide-MHC chimeric antigen ligands
05/15/2022 - 04/30/2026 (PI)
NIH/National Diabetes & Digestive & Kidney Diseases
5R01DK132576-04

Targeting Fibroblast Discoidin Domain Receptor 2 for Immunotherapy to Pulmonary Fibrosis
12/01/2021 - 11/30/2025 (Subcontract PI)
Regents of the University of Michigan NIH NHLBI
5R01HL156998-04

Multiplexed Optogenetic Control of Mammalian Genome and Transcriptome using Recombinases and Cas13
07/01/2023 - 06/30/2025 (Key Person / Mentor)
NIH/National Institute of General Medical Sciences
5F31GM149163-02

Showing 10 of 30 results. Show All Results


Title


Yr Title Project-Sub Proj Pubs
2025 Modified saRNA Encoded BiTEs for Lung Cancer 1R01CA296810-01
2025 Engineering recombinase circuits for cellular diagnostic devices 5R01EB036085-02
2025 Precise targeting of T1D specific T cells using CAR and peptide-MHC chimeric antigen ligands 5R01DK132576-04
2025 Precise tumor targeting with logic CAR circuits 5U01CA265713-05
2024 Engineering recombinase circuits for cellular diagnostic devices 1R01EB036085-01
2024 Precise targeting of T1D specific T cells using CAR and peptide-MHC chimeric antigen ligands 5R01DK132576-03
2024 Multiplexed and Logical Control of the Mammalian Transcriptome Using Cas13 5R01EB031904-04
2024 Precise tumor targeting with logic CAR circuits 5U01CA265713-04
2023 Precise targeting of T1D specific T cells using CAR and peptide-MHC chimeric antigen ligands 5R01DK132576-02
2023 Multiplexed and Logical Control of the Mammalian Transcriptome Using Cas13 5R01EB031904-03
Showing 10 of 22 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Website       Copy PMIDs To Clipboard

  1. Dessai CVP, Huang Z, Lin H, Ding G, He H, Siddiqui M, Zhang M, Wong W, Cheng JX. Cholesterol metabolism modulation facilitates CAR-T induced killing of ovarian cancer. bioRxiv. 2025 Aug 24. PMID: 40894596; PMCID: PMC12393578; DOI: 10.1101/2025.08.20.671345;
     
  2. Bansal A, Wong SW, Wong WKM, Best G, James S, Glastras S, Pena A, Qin CX, Tan SM, Deliyanti D, Rojas-Canales DM, Joglekar MV, Ekinci EI. Novel Molecular Signatures of Peripheral Regulatory T Cells in Kidney Disease Associated With Type 1 Diabetes. Kidney360. 2025 Aug 14. PMID: 40811035
     
  3. Lawton ML, Inge MM, Blum BC, Smith-Mahoney EL, Bolzan D, Lin W, McConney C, Porter J, Moore J, Youssef A, Tharani Y, Varelas X, Denis GV, Wong WW, Padhorny D, Kozakov D, Siggers T, Wuchty S, Snyder-Cappione J, Emili A. Multiomic profiling of chronically activated CD4+ T cells identifies drivers of exhaustion and metabolic reprogramming. PLoS Biol. 2024 Dec; 22(12):e3002943.View Related Profiles. PMID: 39689157; PMCID: PMC11703073; DOI: 10.1371/journal.pbio.3002943;
     
  4. McGee JE, Kirsch JR, Kenney D, Cerbo F, Chavez EC, Shih TY, Douam F, Wong WW, Grinstaff MW. Complete substitution with modified nucleotides in self-amplifying RNA suppresses the interferon response and increases potency. Nat Biotechnol. 2025 May; 43(5):720-726.View Related Profiles. PMID: 38977924; PMCID: PMC11707045; DOI: 10.1038/s41587-024-02306-z;
     
  5. Adams SC, Nambiar AK, Bressler EM, Raut CP, Colson YL, Wong WW, Grinstaff MW. Immunotherapies for locally aggressive cancers. Adv Drug Deliv Rev. 2024 Jul; 210:115331.View Related Profiles. PMID: 38729264; PMCID: PMC11228555; DOI: 10.1016/j.addr.2024.115331;
     
  6. Frankel NW, Deng H, Yucel G, Gainer M, Leemans N, Lam A, Li Y, Hung M, Lee D, Lee CT, Banicki A, Tian M, Almudhfar N, Naitmazi L, Roguev A, Lee S, Wong W, Gordley R, Lu TK, Garrison BS. Precision off-the-shelf natural killer cell therapies for oncology with logic-gated gene circuits. Cell Rep. 2024 May 28; 43(5):114145. PMID: 38669141
     
  7. Ding Y, Tous C, Choi J, Chen J, Wong WW. Orthogonal inducible control of Cas13 circuits enables programmable RNA regulation in mammalian cells. Nat Commun. 2024 Feb 21; 15(1):1572. PMID: 38383558; PMCID: PMC10881482; DOI: 10.1038/s41467-024-45795-x;
     
  8. Naung MT, Martin E, Wong W, Razook Z, Utama D, Guy AJ, Harrison ST, Cowman AF, Lin E, Kiniboro B, Laman M, Mueller I, Barry AE. Reticulocyte Binding Protein Homologue 5 is a target of balancing selection in the Plasmodium falciparum population of Papua New Guinea. Front Parasitol. 2023; 2:1288867. PMID: 39816834; PMCID: PMC11731791; DOI: 10.3389/fpara.2023.1288867;
     
  9. Ullah TR, Johansen MD, Balka KR, Ambrose RL, Gearing LJ, Roest J, Vivian JP, Sapkota S, Jayasekara WSN, Wenholz DS, Aldilla VR, Zeng J, Miemczyk S, Nguyen DH, Hansbro NG, Venkatraman R, Kang JH, Pang ES, Thomas BJ, Alharbi AS, Rezwan R, O'Keeffe M, Donald WA, Ellyard JI, Wong W, Kumar N, Kile BT, Vinuesa CG, Kelly GE, Laczka OF, Hansbro PM, De Nardo D, Gantier MP. Pharmacological inhibition of TBK1/IKKe blunts immunopathology in a murine model of SARS-CoV-2 infection. Nat Commun. 2023 Sep 18; 14(1):5666. PMID: 37723181
     
  10. Lee S, Khalil AS, Wong WW. Recent progress of gene circuit designs in immune cell therapies. Cell Syst. 2022 Nov 16; 13(11):864-873.View Related Profiles. PMID: 36395726; PMCID: PMC9681026; DOI: 10.1016/j.cels.2022.09.006;
     
Showing 10 of 47 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 47 publications over 12 distinct years, with a maximum of 7 publications in 2020 and 2021 and 2022

YearPublications
20121
20153
20162
20173
20184
20194
20207
20217
20227
20232
20245
20252

2022 Allen Distinguished Investigator Award
2021 National Academy of Engineering: German-American Frontiers of Engineering Invitee
2018 ACS Synthetic Biology: Young Investigator Award
2018 BU College of Engineering: Early Career Research Excellence Award
2016 NSF: CAREER Award
2015-2018 Boston University: Ignition Award
2013 NIH: Director’s New Innovator Award
2013 BU Engineering: Dean’s Catalyst Award
2009 American Cancer Society: Postdoctoral Fellowship
Contact for Mentoring:

610 Commonwealth Ave
Boston MA 02215
Google Map


Wong's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department